Apthera IOL

Apthera IOL IC-8 Apthera is the first approved small aperture IOL designed to provide extended depth of focus Welcome to the IC-8™ Apthera™ U.S.

page from Bausch + Lomb Surgical. IC-8 Apthera is the first approved small aperture IOL designed to provide extended depth of focus. https://www.bausch.com/terms
• Bausch + Lomb Surgical products are intended for eye care professionals and veterinary professionals use only.
• For a list of product indications, precautions, contraindication and warnings, please click here: https://www.baus

chsurgical.com/safety/ -apthera
• If you are a patient, please consult with your doctor to see if Apthera is right for you. COMMUNITY GUIDELINES
When posting photos, questions, or comments, please respect our guidelines as outlined below, which apply to all U.S. Bausch + Lomb social media channels. Please also note that we reserve the right to remove posts or comments that we determine in our sole discretion to be:
(a) Abusive, defamatory, or obscene;
(b) Fraudulent, deceptive, or misleading;
(c) In violation of any intellectual property right of another;
(d) In violation of any law or regulation, or
(e) Otherwise offensive, graphically or in tone;
(f) Disparaging of third-party products;
(g) Mentions a Bausch + Lomb prescription product by name with a claim of efficacy;
(h) Mentions a side effect of a product. Further, we may contact you for more information. If you wish to contact the FDA directly about a side effect, you can visit www.fda.gov/medwatch or call 1-800-FDA-1088;
(i) Medical advice;
(j) Clearly off-topic or constitutes spam. Any product complaint should be reported to Bausch + Lomb Customer Care at 1-800-553-5340 or [email protected]. Since our social media channels are intended for respectful and productive discourse, anyone repeatedly posting material that falls into the above categories will not be allowed to further engage with those social channels. These users will also be blocked from engaging with those pages, where available. These community guidelines are for Bausch + Lomb social media channels in the United States. Please note that our social media channels are in English only. Please note that Bausch + Lomb does not necessarily endorse, nor is responsible for, the accuracy of information, opinions, claims, or advice shared by followers or commenters of Bausch + Lomb’s social channels. For any questions about Bausch + Lomb or its product, please call 1-800-553-5340.

12/22/2025

"𝗚𝗶𝘃𝗲 𝗣𝗮𝘁𝗶𝗲𝗻𝘁𝘀 𝗮 𝗟𝗶𝗳𝗲𝘁𝗶𝗺𝗲 𝗼𝗳 𝗕𝗲𝗻𝗲𝗳𝗶𝘁"
Hear Dr. Eric Donnenfeld, MD talk about how implanting enVista Envy™ IOLs is always the exciting part of his day and how the reports of low visual disturbances by patients post-op could be the nudge some ophthalmologists need to confidently evaluate full range of vision IOLs for patients.

Learn More: https://bit.ly/4hlHf6F

For indications and important safety information, visit: https://bit.ly/4nKCrK8

𝗣𝗮𝘁𝗶𝗲𝗻𝘁 𝗣𝗲𝗿𝘀𝗽𝗲𝗰𝘁𝗶𝘃𝗲𝘀: 𝗲𝗻𝗩𝗶𝘀𝘁𝗮 𝗘𝗻𝘃𝘆™ "𝗜 𝗰𝗼𝘂𝗹𝗱 𝘀𝗲𝗲 𝗽𝗿𝗲𝘁𝘁𝘆 𝗰𝗹𝗲𝗮𝗿𝗹𝘆 𝗿𝗶𝗴𝗵𝘁 𝗮𝘄𝗮𝘆"Following implantation of enVista Envy™ IOLs,...
12/19/2025

𝗣𝗮𝘁𝗶𝗲𝗻𝘁 𝗣𝗲𝗿𝘀𝗽𝗲𝗰𝘁𝗶𝘃𝗲𝘀: 𝗲𝗻𝗩𝗶𝘀𝘁𝗮 𝗘𝗻𝘃𝘆™
"𝗜 𝗰𝗼𝘂𝗹𝗱 𝘀𝗲𝗲 𝗽𝗿𝗲𝘁𝘁𝘆 𝗰𝗹𝗲𝗮𝗿𝗹𝘆 𝗿𝗶𝗴𝗵𝘁 𝗮𝘄𝗮𝘆"
Following implantation of enVista Envy™ IOLs, a recent patient reported
significant improvements in daily vision, especially when driving at night. Friends even jealously noticed she could thread a sewing needle without glasses.
“𝗜𝘁’𝘀 𝘀𝗼 𝘄𝗼𝗿𝘁𝗵 𝗶𝘁 𝗶𝗻 𝘁𝗵𝗲 𝗲𝗻𝗱.”

Individual results may vary.

Learn More: https://bit.ly/42M0ZKB

For indications and important safety information, visit: https://bit.ly/4nKCrK8

📣 𝗠𝗶𝗹𝗲𝘀𝘁𝗼𝗻𝗲: 𝗨.𝗦. 𝘀𝘂𝗿𝗴𝗲𝗼𝗻𝘀 𝗵𝗮𝘃𝗲 𝗶𝗺𝗽𝗹𝗮𝗻𝘁𝗲𝗱 𝟮𝟱,𝟬𝟬𝟬+ 𝗲𝗻𝗩𝗶𝘀𝘁𝗮 𝗘𝗻𝘃𝘆™ 𝗜𝗢𝗟𝘀.Bausch + Lomb is proud to partner with forward-thin...
12/16/2025

📣 𝗠𝗶𝗹𝗲𝘀𝘁𝗼𝗻𝗲: 𝗨.𝗦. 𝘀𝘂𝗿𝗴𝗲𝗼𝗻𝘀 𝗵𝗮𝘃𝗲 𝗶𝗺𝗽𝗹𝗮𝗻𝘁𝗲𝗱 𝟮𝟱,𝟬𝟬𝟬+ 𝗲𝗻𝗩𝗶𝘀𝘁𝗮 𝗘𝗻𝘃𝘆™ 𝗜𝗢𝗟𝘀.

Bausch + Lomb is proud to partner with forward-thinking surgeons across the U.S. who are committed to innovations which support patient needs, empowering them to 𝗙𝗹𝗼𝘂𝗿𝗶𝘀𝗵 𝗔𝘁 𝗘𝘃𝗲𝗿𝘆 𝗦𝘁𝗲𝗽. 🦚

Connect with your B+L representative to learn more.

12/08/2025

"𝗢𝗻𝗲 𝗼𝗳 𝘁𝗵𝗲 𝗘𝗮𝘀𝗶𝗲𝘀𝘁 𝗟𝗲𝗻𝘀𝗲𝘀 𝘁𝗼 𝗚𝗲𝘁 𝗜𝗻𝘁𝗼 𝘁𝗵𝗲 𝗘𝘆𝗲"
Hear Dr. Lisa Feulner, MD, PhD discuss the simplicity of the enVista Envy™ and how the range of toric treatment options enables her to reduce the astigmatism as much as possible, setting it apart from other presbyopia-correcting IOLs.

Learn More: https://bit.ly/4hlHf6F

For indications and important safety information, visit: https://bit.ly/4nKCrK8

11/25/2025

"𝗣𝗮𝘁𝗶𝗲𝗻𝘁 𝗦𝗮𝘁𝗶𝘀𝗳𝗮𝗰𝘁𝗶𝗼𝗻 𝗶𝘀 𝗪𝗵𝗮𝘁 𝗜𝘁'𝘀 𝗔𝗹𝗹 𝗔𝗯𝗼𝘂𝘁"
Hear Dr. Paul Singh, MD discuss how enVista Envy™ has allowed him to achieve patients that are "20 Happy" and address their expectations for distance vision, low-light contrast vision, and functional near vision for a confident full range of vision.

Learn More: https://bit.ly/4hlHf6F

For indications and important safety information, visit: https://bit.ly/4nKCrK8

𝗣𝗮𝘁𝗶𝗲𝗻𝘁 𝗣𝗲𝗿𝘀𝗽𝗲𝗰𝘁𝗶𝘃𝗲𝘀: 𝗲𝗻𝗩𝗶𝘀𝘁𝗮 𝗘𝗻𝘃𝘆™ "𝗜𝘁'𝘀 𝗯𝗲𝗲𝗻 𝗮 𝘄𝗼𝗻𝗱𝗲𝗿𝗳𝘂𝗹 𝗲𝘅𝗽𝗲𝗿𝗶𝗲𝗻𝗰𝗲."Following implantation of enVista Envy™ IOLs, a r...
11/19/2025

𝗣𝗮𝘁𝗶𝗲𝗻𝘁 𝗣𝗲𝗿𝘀𝗽𝗲𝗰𝘁𝗶𝘃𝗲𝘀: 𝗲𝗻𝗩𝗶𝘀𝘁𝗮 𝗘𝗻𝘃𝘆™
"𝗜𝘁'𝘀 𝗯𝗲𝗲𝗻 𝗮 𝘄𝗼𝗻𝗱𝗲𝗿𝗳𝘂𝗹 𝗲𝘅𝗽𝗲𝗿𝗶𝗲𝗻𝗰𝗲."
Following implantation of enVista Envy™ IOLs, a recent patient reported clearer vision across distances with reduced reliance on glasses for reading watching TV.

Individual results may vary.

Learn More: https://bit.ly/42M0ZKB

For indications and important safety information, visit: https://bit.ly/4nKCrK8

10/10/2025

📢 𝗡𝗼𝘄 𝗣𝘂𝗯𝗹𝗶𝘀𝗵𝗲𝗱 𝗶𝗻 𝘁𝗵𝗲 𝗔𝗺𝗲𝗿𝗶𝗰𝗮𝗻 𝗝𝗼𝘂𝗿𝗻𝗮𝗹 𝗼𝗳 𝗢𝗽𝗵𝘁𝗵𝗮𝗹𝗺𝗼𝗹𝗼𝗴𝘆
Results from the pivotal U.S. clinical trial of the enVista Envy™ are in and confirms the full range of vision IOL is a strong option for surgeons committed to advancing outcomes in cataract care.

🔹 Met all primary efficacy & safety endpoints in a multicenter study
🔹 Delivered excellent visual performance & contrast sensitivity
🔹 Showed a favorable dysphotopsia profile
🔹 Demonstrated consistent visual acuity of ~0.1 logMAR from -1.50 to -2.50D

“Trial results mirror what I have seen in my practice… I will continue to rely on enVista Envy™ as an excellent option for cataract patients seeking a full range of vision with minimal visual disturbances, as well as precision astigmatism correction.”
— Dr. Mitchell Shultz, lead author

🔗 https://loom.ly/nFgkD-Q

10/08/2025

🪷 𝗛𝗮𝗿𝗻𝗲𝘀𝘀 𝘁𝗵𝗲 𝗣𝗼𝘄𝗲𝗿 𝗼𝗳 𝗙𝗼𝗰𝘂𝘀𝗲𝗱 𝗟𝗶𝗴𝗵𝘁
𝗦𝘄𝗶𝗽𝗲 𝘁𝗵𝗿𝗼𝘂𝗴𝗵 𝘁𝗼 𝘀𝗲𝗲 𝗵𝗼𝘄 𝘁𝗵𝗲 𝗜𝗖-𝟴® 𝗔𝗽𝘁𝗵𝗲𝗿𝗮™ 𝗜𝗢𝗟 can help deliver:

✅ Continuous range of vision with reduced blurry zones
✅ Enhanced retinal image quality through selective light filtering
✅ Reliable monofocal-like distance vision, plus improved intermediate and near focus

Support your patients’ visual goals with precision and confidence.

🔗: https://www.bauschsurgical.com/cataract/ic-8-apthera-iol

09/29/2025

𝗲𝗻𝗩𝗶𝘀𝘁𝗮 𝗘𝗻𝘃𝘆™ - 𝗘𝘅𝗰𝗲𝗽𝘁𝗶𝗼𝗻𝗮𝗹 𝘃𝗶𝘀𝗶𝗼𝗻 𝗮𝘁 𝗲𝘃𝗲𝗿𝘆 𝗱𝗶𝘀𝘁𝗮𝗻𝗰𝗲. 👁

Experience outstanding visual acuity with enVista Envy™, delivering excellent results across near, intermediate, and distance vision.

Elevate your expectations, learn more at www.bauschsurgical.com/cataract/enVista-Envy/

For safety information, visit https://www.bauschsurgical.com/safety/ -envy

09/24/2025

🪷 𝗛𝗮𝗿𝗻𝗲𝘀𝘀 𝘁𝗵𝗲 𝗣𝗼𝘄𝗲𝗿 𝗼𝗳 𝗙𝗼𝗰𝘂𝘀𝗲𝗱 𝗟𝗶𝗴𝗵𝘁 𝘄𝗶𝘁𝗵 𝗜𝗖 - 𝟴® 𝗔𝗽𝘁𝗵𝗲𝗿𝗮 ™ 𝗜𝗢𝗟𝘀

𝗧𝗵𝗲 𝗜𝗖 - 𝟴® 𝗔𝗽𝘁𝗵𝗲𝗿𝗮 ™ 𝗜𝗢𝗟 delivers a continuous range of vision to support everyday activities without blurry zones. By filtering out defocused light, it focuses only high-quality light onto the retina, enhancing visual clarity from near to far and effectively managing mild astigmatism.

🔗: https://bit.ly/4fwwxcp

For indications and important safety information, visit:
https://www.bauschsurgical.com/safety/ -apthera

Congratulations to Dr. Jerry Hu and his team at Texas Eye and Laser Center in Hurst, Texas for providing his patients wi...
09/08/2025

Congratulations to Dr. Jerry Hu and his team at Texas Eye and Laser Center in Hurst, Texas for providing his patients with the IC-8™ Apthera™, the first FDA-approved small aperture IOL designed to extend depth of focus. Mark R Mandel, M.D. https://bit.ly/45UzMWh

Texas Eye and Laser Center

Address

400 Somerset Corporate Boulevard
Bridgewater, NJ
08807

Alerts

Be the first to know and let us send you an email when Apthera IOL posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Apthera IOL:

Share

Category